Methylthioninium chloride Proveblue (methylthioninium chloride)
- Region
- 🇪🇺 EU
- Active substance
- methylthioninium chloride
- Company
- Provepharm SAS
- Status
- Authorised
- Therapeutic area
- Methemoglobinemia
- EU approval
- Fri 06 May 2011
- Application
- EMEA/H/C/002108
- ATC
- V03AB17
- Official record
- www.ema.europa.eu
Indication
Acute symptomatic treatment of medicinal and chemical products- induced methaemoglobinaemia. Methylthioninium chloride Proveblue is indicated in adults, children and adolescents (aged 0 to 17 years old).
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Lumeblue (previously Methylthioninium chloride Cosmo) Authorised · Cosmo Technologies Ltd
Follow Methylthioninium chloride Proveblue
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.